|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.485 USD | -0.09% |
|
-1.50% | +60.89% |
| Jun. 16 | CureVac agrees to pay Biontech termination fee Of $43.8 mln under specified circumstances | RE |
| Jun. 13 | Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability (Composite) | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
| 1.24B | - | |||||
| 48.12B | ||||||
| 29.99B | ||||||
| 31.33B | - | - | - | - | - | |
| 26.75B | ||||||
| 25.65B |
- Stock Market
- Equities
- CVAC Stock
- Charts CureVac N.V.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
